Agilent Expands Life Science Disease Research Portfolio with Eurofins MWG Operon Asset Purchase

News   Nov 17, 2009

 
Agilent Expands Life Science Disease Research Portfolio with Eurofins MWG Operon Asset Purchase
 
 
 

RELATED ARTICLES

CRISPR Technology Used to Make Stem Cells

News

In a world first, CRISPR genome editing has been used to reprogram skin cells to function as pluripotent stem cells.

READ MORE

Magnetic MicroRNAs Could Help Treat Incontinence

News

An unlikely combination of magnets and MicroRNAs might be a novel treatment for constipation and incontinence patients.

READ MORE

Meteorite Dust Charts History of the Solar System

News

Using a state-of-the-art mass spectrometer to measure the titanium isotopes in supernova SiC grains, scientists have been able to test theoretical calculations about the origins of the solar system.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE